AU2108997A - Adhesion inhibitors, preparation comprising them and method for producing them - Google Patents

Adhesion inhibitors, preparation comprising them and method for producing them

Info

Publication number
AU2108997A
AU2108997A AU21089/97A AU2108997A AU2108997A AU 2108997 A AU2108997 A AU 2108997A AU 21089/97 A AU21089/97 A AU 21089/97A AU 2108997 A AU2108997 A AU 2108997A AU 2108997 A AU2108997 A AU 2108997A
Authority
AU
Australia
Prior art keywords
producing
preparation
adhesion inhibitors
inhibitors
adhesion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU21089/97A
Inventor
Patricia Lynne Conway
Arthur Ouwehand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arla Ekonomisk Forening
Original Assignee
Arla Ekonomisk Forening
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arla Ekonomisk Forening filed Critical Arla Ekonomisk Forening
Publication of AU2108997A publication Critical patent/AU2108997A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU21089/97A 1996-02-26 1997-02-25 Adhesion inhibitors, preparation comprising them and method for producing them Abandoned AU2108997A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9600716 1996-02-26
SE9600716A SE508045C2 (en) 1996-02-26 1996-02-26 Adhesion inhibitors, preparations containing the same and process for their preparation
PCT/SE1997/000313 WO1997030717A1 (en) 1996-02-26 1997-02-25 Adhesion inhibitors, preparation comprising them and method for producing them

Publications (1)

Publication Number Publication Date
AU2108997A true AU2108997A (en) 1997-09-10

Family

ID=20401546

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21089/97A Abandoned AU2108997A (en) 1996-02-26 1997-02-25 Adhesion inhibitors, preparation comprising them and method for producing them

Country Status (5)

Country Link
EP (1) EP0904091A1 (en)
AU (1) AU2108997A (en)
CA (1) CA2243067A1 (en)
SE (1) SE508045C2 (en)
WO (1) WO1997030717A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001010448A1 (en) * 1999-08-09 2001-02-15 University Of Maryland, Baltimore Pro-gut maturation and anti-inflammatory effects of lactobacillus and lactobacillus secreted proteins, carbohydrates and lipids
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
ME02997B (en) 2014-12-23 2018-10-20 4D Pharma Res Ltd A bacteroides thetaiotaomicron strain and its use in reducing inflammation
WO2016102951A1 (en) 2014-12-23 2016-06-30 4D Pharma Research Limited Pirin polypeptide and immune modulation
PL3206700T3 (en) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprising bacterial strains
CN115364122A (en) 2015-06-15 2022-11-22 4D制药研究有限公司 Compositions comprising bacterial strains
MA41060B1 (en) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprising bacterial strains
MD3307288T2 (en) 2015-06-15 2019-12-31 4D Pharma Res Ltd Compositions comprising bacterial strains
MA41010B1 (en) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
EA034677B1 (en) 2015-11-20 2020-03-05 4Д Фарма Рисёрч Лимитед Compositions for treating or preventing cancer comprising enterococcus gallinarum strain
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
DK3313423T3 (en) 2016-03-04 2019-05-20 4D Pharma Plc COMPOSITIONS INCLUDING BACTERIAL BLAUTIA STAMPS FOR TREATMENT OF VISCERAL HYPERSENSITIVITY
TWI802545B (en) 2016-07-13 2023-05-21 英商４Ｄ製藥有限公司 Compositions comprising bacterial strains
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
LT3630136T (en) 2017-05-22 2021-06-10 4D Pharma Research Limited Compositions comprising bacterial strains
WO2018215782A1 (en) 2017-05-24 2018-11-29 4D Pharma Research Limited Compositions comprising bacterial strain
IL283973B (en) 2017-06-14 2022-08-01 4D Pharma Res Ltd Compositions comprising bacterial strains
HUE052258T2 (en) 2017-06-14 2021-04-28 4D Pharma Res Ltd Compositions comprising a bacterial strain of the genus megasphaera and uses thereof
EP3638271B1 (en) 2017-06-14 2020-10-14 4D Pharma Research Limited Compositions comprising bacterial strains

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8900546D0 (en) * 1989-02-17 1989-02-17 Bioinvent Int Ab Means for inhibiting pathogens' growth and / or survival

Also Published As

Publication number Publication date
EP0904091A1 (en) 1999-03-31
SE9600716D0 (en) 1996-02-26
CA2243067A1 (en) 1997-08-28
SE508045C2 (en) 1998-08-17
SE9600716L (en) 1997-08-27
WO1997030717A1 (en) 1997-08-28

Similar Documents

Publication Publication Date Title
AU2108997A (en) Adhesion inhibitors, preparation comprising them and method for producing them
AU3373599A (en) Method, and system for product configuration
AU6113198A (en) Method and system for improving communication
AU694837B2 (en) Naphthyl compounds, intermediates, compositions, and methods
AU2053099A (en) Method for producing low-molecular, highly reactive polyisobutylene
AU1940397A (en) Forming method and forming system
AU2046297A (en) Method for the manufacture of ammonia
AU5317398A (en) Method for preparing cyclopropylamines
AU5751298A (en) Method for producing arylcyanates
AU7036198A (en) Improved method for producing thiazolidinediones, and new thiazolidinediones
AU3327097A (en) Laminate, process for its preparation and its use
AU2183997A (en) New method
AU3704297A (en) Method
AU3936699A (en) Novel vinca-alkaloid derivatives and preparation method
AU7088896A (en) Laminated glazing, method for making same, and method for mounting and using said glazing
AU1563900A (en) Depositing method and arrangement
AU3636895A (en) Freezing method
AU5479898A (en) New knoevenagel condensation products, method for their production and their use
AU5854598A (en) Method for producing 1-phenyl-uracil derivatives
AUPO937097A0 (en) Method
AUPO870297A0 (en) Method
AU2916797A (en) Insulation element, method for preparing same, and use of the insulation element
AU2094700A (en) Method for producing pyrazolylbenzoyl derivatives and novel pyrazolylbenzoyl derivatives
AU9169398A (en) Soundproofing product and method for making same
AU4776397A (en) Shoe and method for its production